Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective

Wheeler Torres1, Manuel Nava1, Nestor Galbán1

  • 1Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela

Insights

Metformin, a diabetes drug, shows promise in extending lifespan and improving healthspan in model organisms. Research is exploring its anti-aging mechanisms and potential as a human therapy.

Area of Science:

  • Gerontology
  • Pharmacology
  • Cellular Biology

Background:

  • Aging impacts cellular homeostasis and increases non-transmissible disease risk.
  • Metformin, a Type 2 Diabetes Mellitus drug, has a favorable safety profile.
  • Emerging evidence suggests metformin possesses health benefits beyond glucose control, including geroprotective effects.

Purpose of the Study:

  • To investigate metformin's potential as an anti-aging therapy.
  • To explore the mechanisms underlying metformin's geroprotective capabilities.
  • To assess the potential for clinical trials evaluating metformin's efficacy and safety in humans for anti-aging.

Main Methods:

  • Review of existing scientific literature on metformin and aging.
  • Analysis of studies in model organisms demonstrating increased lifespan and quality of life with metformin.
  • Identification of key molecular pathways implicated in metformin's anti-aging effects.

Main Results:

  • Metformin treatment has been linked to increased life expectancy and improved quality of life in various model organisms.
  • Key molecular pathways potentially mediating metformin's anti-aging effects include AMPK, mTORC1, SIRT1, FOXO, NF-kB, and DICER1.
  • The gut microbiome may play a role in metformin's geroprotective actions.

Conclusions:

  • Metformin exhibits significant geroprotective properties in preclinical studies.
  • Further research into metformin's anti-aging mechanisms is warranted.
  • Clinical trials are necessary to determine metformin's efficacy and safety as an anti-aging intervention in humans.

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
511
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
118
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
125
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
490